Company News: Page (1) of 1 - 09/08/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting

First Presentation of Detailed EVENITY ARCH Study Results and FRAME Extension Final Analysis10-Year Data From Long-Term Prolia FREEDOM Study (September 08, 2017)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Business Issues,Administration,Legal,Management,Sales,Sales,Pro AV,Post/Production,Management,Presentors,Management,Business,Marketing,Business Issues,

-->

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved